{"entity":{"type":"insider","cik":"0001799365","url":"/insider/0001799365","json_url":"/insider/0001799365.json","name":"Bigora Sian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2026-04-01","last":"2026-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Bigora Sian","source":"filing","n_filings":4,"first_seen":"2026-04-01","last_seen":"2026-05-19"}],"transactions":[{"id":5974565,"accession":"0000897069-26-001154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001154","line_url":"/filing/0000897069-26-001154#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799365","owner_name":"Bigora Sian","owner_display_name":"Bigora Sian","owner_url":"/insider/0001799365","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1971.0,"shares_display":"1,971","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":5341.41,"total_display":"5,341.41","total_whole":"5,341","shares_owned_after":7481.0,"shares_owned_after_display":"7,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-19","scope":"insider"},{"id":5817524,"accession":"0000897069-26-001000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001000","line_url":"/filing/0000897069-26-001000#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799365","owner_name":"Bigora Sian","owner_display_name":"Bigora Sian","owner_url":"/insider/0001799365","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1986.0,"shares_display":"1,986","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":5342.34,"total_display":"5,342.34","total_whole":"5,342","shares_owned_after":7496.0,"shares_owned_after_display":"7,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-01","scope":"insider"},{"id":5738447,"accession":"0000897069-26-000904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000904","line_url":"/filing/0000897069-26-000904#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799365","owner_name":"Bigora Sian","owner_display_name":"Bigora Sian","owner_url":"/insider/0001799365","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1799.0,"shares_display":"1,799","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":5343.03,"total_display":"5,343.03","total_whole":"5,343","shares_owned_after":5510.0,"shares_owned_after_display":"5,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"},{"id":6124446,"accession":"0000897069-26-000743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000743","line_url":"/filing/0000897069-26-000743#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799365","owner_name":"Bigora Sian","owner_display_name":"Bigora Sian","owner_url":"/insider/0001799365","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2107.0,"shares_display":"2,107","price_per_share":2.535,"price_display":"2.54","price_state":"stated","total_value":5341.245,"total_display":"5,341.24","total_whole":"5,341","shares_owned_after":3711.0,"shares_owned_after_display":"3,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533743","name":"Processa Pharmaceuticals, Inc.","url":"/issuer/0001533743","role":"Officer (Chief Development Officer)","n_filings":4,"first_seen":"2026-04-01","last_seen":"2026-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001799365","retrieved_at":"2026-08-26T04:23:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}